Outpatient surgery patients also at risk for dangerous blood clots

A University of Michigan Health System study examined who’s having outpatient surgery in the U.S. today, and showed 1 in 84 highest-risk patients suffers a dangerous blood clot after surgery.

Hospitalized patients are often warned of the possibility of venous thromboembolism, which include blood clots that can form in the veins and travel to the lungs.

However these warnings have not necessarily been extended to the outpatient surgery population, says U-M surgeon and lead study author Christopher J. Pannucci, M.D.

With more than 60 percent of procedures now being done in the outpatient setting, the U-M study revealed a need for better patient screening of the large and growing group of patients having outpatient surgery.

“Once a setting for those having simple procedures, outpatient surgery now includes a greater variety of procedures from plastic surgery to cancer operations and orthopedic surgery, and not all patients are young, healthy individuals,” says Pannucci, a resident in the U-M Section of Plastic Surgery.

Previous research shows that despite an increase in the presence of VTE risk factors among patients, such as advanced age and obesity, fewer than 50 percent of outpatient centers have VTE prevention guidelines, and even fewer adhere to them.

The U-M study published online ahead of print in Annals of Surgery provides a view of what drives an increased risk for VTE in the changing outpatient surgery environment.

Researchers evaluated more than 200,000 outpatient surgeries at centers across the country included in the American College of Surgeons’ National Surgical Quality Improvement Program Participant Use File.

Vein surgery and arthroscopic surgery are important drivers of VTE risk, which is well-known, but the U-M analysis showed that a majority of patients had multiple factors that could put them at risk for blood clots. Age, surgery length, current pregnancy, active cancer and type of surgical procedure were all indicators of VTE risk.

With the information, the researchers created and validated a risk-stratification tool that can be used to predict a patient’s risk for VTE. The tool identified a 20-fold variation in VTE risk from 0.04 percent to 1.12 percent among the outpatient surgery population.

“These data are in stark contrast to provider and patient expectations that outpatient surgery is a low-risk event,” Pannucci says. “It also underscores the importance of evaluating a patient’s individual risk factors as opposed to procedure-type alone.”

The risk model identified by the U-M may improve the informed consent process for outpatient surgery patients by providing clear, data-driven information to patients about their risk for developing VTE, authors say.

Prevention of VTE is considered a major patient safety issue and indicator of quality care by the U.S. Surgeon General.

As a result, hospitals, including the University of Michigan Health System, have developed robust VTE prevention guidelines for patients.

Additional authors: Amy Shanks, Marc J. Moote, PA-C, Vinita Bahl, Paul S. Cederna, M.D., Norah H. Naughton, M.D., Thomas W. Wakefield, M.D., Peter K. Henke, M.D., Darrell A. Campbell, M.D., and Sachin Keterpal, M.D., all of the U-M.

Reference: “Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery,” Annals of Surgery, April 23, 2012.

Media Contact

Shantell M. Kirkendoll EurekAlert!

More Information:

http://www.umich.edu

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Distance learning can improve women’s access to vocational training as animal health care practitioners in Nepal. Image Credit: Heifer International

Hybrid Job Training Boosts Women’s Participation in Nepal

Globally, women’s workforce participation is about 25% lower than men’s, often due to barriers such as domestic responsibilities and cultural norms. Vocational training can increase employment opportunities, but women may…

CO2release increase under repeated drying-rewetting cycles (DWCs). Image Credit: Suzuki, Nagano et al., 2025 SOIL

Drying and Rewetting Cycles Boost Soil CO2 Emissions

Niigata, Japan – The amount of carbon dioxide (CO2) released by microbial decomposition of soil organic carbon on a global scale is approximately five times greater than the amount of…

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers. Oregon State's Olena Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon Health & Science University, designed a type of drug nanocarrier known as a polymersome to specifically target a protein in choriocarcinoma cells. Depicted is a polymersome with its methotrexate cargo. Illustration by Parinaz Ghanbari. Image Credit: Parinaz Ghanbari

Improved Treatment Method for Rare Pregnancy-Related Cancer

PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other…